Ignite Creation Date:
2024-05-06 @ 8:58 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02866383
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2016-08-08
Brief Title:
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
GI 1616
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herlev Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Inna Chen MD
Responsible Party Title:
Staff Specialist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Herlev Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |